Recovery Wear with 'Resonance' Blood Flow Promotion Mechanism Certified as General Medical Device to Launch in June

Takihyo Co., Ltd. will begin selling recovery wear in June 2026, featuring a blood flow promotion mechanism developed by Resona Bio LAB that uses resonance to dilate blood vessels. These garments are registered as general medical devices and will be rolled out sequentially to mass retailers nationwide.

■ Key Features

- Unique Blood Flow Promotion Mechanism via 'Resonance'
While many recovery wear products on the market use 'radiant heat' to absorb and re-emit body heat, this product utilizes a 'resonance' effect generated by matching the frequencies of far-infrared rays emitted from the skin with those emitted by special fibers.
This micro-vibration works on the human body to effectively dilate blood vessels and promote blood flow.

- Unmatched Texture and Comfort via 'Cotton Blend'
Designed for daily use, including sleep, the material is carefully selected. Unlike many products primarily made of synthetic fibers (such as polyester), this launch product contains approximately 45% cotton, providing superior texture and sweat absorption for a more comfortable relaxation experience.

- Evidence via General Medical Device Registration
In collaboration with Resona Bio LAB, the product has obtained evidence as a general medical device (Medical Device Notification Number: 47B3X10001TH0001).

Moving forward, the company plans to sequentially expand into various materials to support comfortable rest across different seasons and scenarios. Additionally, it will actively cater to the previously underserved demand for children and school-age generations, supporting 'high-quality rest and fatigue recovery' for all generations.